[1]
Lilleby, O. et al. 2023. Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trials. Scandinavian Journal of Urology. 58, (Jun. 2023), 21–27. DOI:https://doi.org/10.2340/sju.v58.7719.